A recent study has revealed that mothers who take Xarelto can pass down the drug to their unborn child. When ingested during pregnancy, the anticoagulant transfers back and forth across the placenta between a mother and her fetus. The study was done by a research team at The Motherisk Program at the Hospital for Sick Children in Toronto and published most recently in the American Journal of Obstetrics & Gynecology. They initially began the study in order to discover the degree of transfer of the drug and what potential side effects would occur.
Although they were able to prove that Xarelto did transfer from a mother to her fetus, they will need to conduct additional studies to better understand whether or not it would be safe to administer Xarelto to a pregnant woman. In some high-risk pregnancies, anti-coagulants are a necessary treatment for expecting mothers. Unfortunately, Xarelto does not yet have an antidote and if it is given to pregnant women, it may pose a risk for her fetus. For this reason, researchers have indicated that further studies are needed to better understand this risk.
Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.